Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02386111 |
Title | A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Celldex Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham | Birmingham | Alabama | 35294 | United States | Details | |
UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
UCSF Helen Diller Comprehensive Cancer Center | San Francisco | California | 94158 | United States | Details | |
George Washington University-Medical Faculty Associates | Washington | District of Columbia | 20037 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | United States | Details | |
Mount Sinai Medical Center | New York | New York | 10029 | United States | Details | |
Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | United States | Details |